A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer
We have developed a UbRGs-based signature for LC prognostic evaluation that is valuable in clinical application, indicative of the immune microenvironment and beneficial for individualized treatment guidance.
Authors
- Bing Wang (ORCID: https://orcid.org/0000-0001-7315-2185)
- Lu Liu (ORCID: https://orcid.org/0000-0002-7833-5252)
- Xudong Wei (ORCID: https://orcid.org/0000-0002-3325-0837)
- Xiaoya Ma (ORCID: https://orcid.org/0000-0001-8249-0178)
- Lei Tan (ORCID: https://orcid.org/0009-0003-8989-1208)
Institutions
- Chinese Academy of Sciences (CN)
- Soochow University (CN)
- Gansu Provincial Hospital (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- Jiangxi Provincial Children's Hospital (CN)
- First Hospital of Lanzhou University (CN)
- Lanzhou University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3389/fphar.2025.1513948
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China